Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Among authors: tsiodras s. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
Grigoropoulos I, Tsioulos G, Kastrissianakis A, Shapira S, Green O, Rapti V, Tsakona M, Konstantinos T, Savva A, Kavatha D, Boumpas D, Syrigos K, Xynogalas I, Leontis K, Ntousopoulos V, Sakka V, Sardelis Z, Fotiadis A, Vlassi L, Kontogianni C, Levounets A, Poulakou G, Gaga M, MacLoughlin R, Stebbing J, Arber N, Antoniadou A, Tsiodras S. Grigoropoulos I, et al. Among authors: tsiodras s. Respir Res. 2024 Apr 1;25(1):151. doi: 10.1186/s12931-024-02759-5. Respir Res. 2024. PMID: 38561798 Free PMC article.
The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination.
Speletas M, Bakaros E, Peristeri AM, Voulgaridi I, Sarrou S, Paliatsa V, Nasika A, Tseroni M, Anagnostopoulos L, Theodoridou K, Kalala F, Theodoridou A, Mouchtouri BA, Tsiodras S, Eibel H, Hadjichristodoulou C. Speletas M, et al. Among authors: tsiodras s. Int J Mol Sci. 2022 Nov 14;23(22):14056. doi: 10.3390/ijms232214056. Int J Mol Sci. 2022. PMID: 36430533 Free PMC article.
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness.
Feng A, Yang EY, Moore AR, Dhingra S, Chang SE, Yin X, Pi R, Mack EK, Völkel S, Geßner R, Gündisch M, Neubauer A, Renz H, Tsiodras S, Fragkou PC, Asuni AA, Levitt JE, Wilson JG, Leong M, Lumb JH, Mao R, Pinedo K, Roque J, Richards CM, Stabile M, Swaminathan G, Salagianni ML, Triantafyllia V, Bertrams W, Blish CA, Carette JE, Frankovich J, Meffre E, Nadeau KC, Singh U, Wang TT, Luning Prak ET, Herold S, Andreakos E, Schmeck B, Skevaki C, Rogers AJ, Utz PJ. Feng A, et al. Among authors: tsiodras s. JCI Insight. 2023 Feb 8;8(3):e163150. doi: 10.1172/jci.insight.163150. JCI Insight. 2023. PMID: 36752204 Free PMC article.
Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2.
Thomas Κ, Grigoropoulos I, Alexopoulou P, Karofylakis E, Galani I, Papadopoulou KK, Tsiavou A, Ntourou A, Mavrou E, Qevani I, Katsimbri P, Koutsianas C, Mavrea E, Vassilopoulos D, Pournaras S, Tsiodras S, Boumpas D, Antoniadou A. Thomas Κ, et al. Among authors: tsiodras s. Rheumatology (Oxford). 2024 Feb 1;63(2):534-541. doi: 10.1093/rheumatology/kead236. Rheumatology (Oxford). 2024. PMID: 37228039 Free PMC article.
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis.
Stefanou MI, Palaiodimou L, Theodorou A, Christodoulou MV, Tzartos JS, Tzanetakos D, Kitsos D, Chondrogianni M, Zouvelou V, Dardiotis E, Tzavellas E, Syrigou E, Benetou V, Paraskevas GP, Tsiodras S, Tsivgoulis G, Giannopoulos S. Stefanou MI, et al. Among authors: tsiodras s. Mult Scler. 2023 Apr;29(4-5):585-594. doi: 10.1177/13524585221150881. Epub 2023 Feb 1. Mult Scler. 2023. PMID: 36722184 Free PMC article.
Pegylated Interferon Lambda for Covid-19.
Andreakos E, Tsiodras S. Andreakos E, et al. Among authors: tsiodras s. N Engl J Med. 2023 Jun 1;388(22):2107. doi: 10.1056/NEJMc2303519. N Engl J Med. 2023. PMID: 37256988 No abstract available.
356 results